Topamax, Topiramate

Bookmark

Add to MyYahoo RSS

Topamax, Topiramate News

News on Topamax, Topiramate (generic) continually updated from thousands of sources around the net.

Monday | Sys-Con Media

New Data From Upsher-Smith's Epilepsy Portfolio To Be...

Upsher-Smith, a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system , will be sponsoring 13 , is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic profile.

Comment?

Related Topix: Epilepsy, Medicine, Health, Seizures

Tue Apr 08, 2014

BioMed Central

Acute myopia and angle closure glaucoma from topiramate in a...

A case is reported of acute bilateral myopia and angle closure glaucoma in a 7-year-old patient from topiramate toxicity.

Comment?

Related Topix: Medicine, Seizures, Health

Mon Mar 31, 2014

Drugs.com

Topamax Approval for Migraines Expanded to Younger Users

MONDAY March 31, 2014, 2014 -- U.S. Food and Drug Administration approval of the drug Topamax to prevent migraine headaches has been expanded to include adolescents 12 years to 17 years, the agency said Friday.

Comment?

Related Topix: Medicine, Food and Drug Administration, Health, Seizures

Sat Mar 29, 2014

Examiner.com

Topamex approved to manage migraines in teens

Topomax , first drug to treat migrainesfor kids12-17 FDA approval of a drug for migraine prevention in this age group.

Comment?

Related Topix: Medicine, Food and Drug Administration

Fri Mar 28, 2014

The News Journal

FDA approves Topamax for migraine prevention in adolescents

The U.S. Food and Drug Administration approved Topamax on Friday for the prevention of migraine headaches in adolescents ages 12 to 17, the agency announced.

Comment?

Related Topix: Healthcare Law, Food and Drug Administration, Law, Medicine

BioSpace

FDA Ok's Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents

March 28, 2014 -- Today, the U.S. Food and Drug Administration approved Topamax for prevention of migraine headaches in adolescents ages 12 to 17. This is the first FDA approval of a drug for migraine prevention in this age group.

Comment?

Related Topix: Medicine, Healthcare Law, Law, Food and Drug Administration

•••
•••
•••
•••
•••
•••
•••
•••